- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: eudract_number:2017-003583-12.
Displaying page 1 of 1.
EudraCT Number: 2017-003583-12 | Sponsor Protocol Number: CA224-047 | Start Date*: 2018-05-30 | ||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | ||||||||||||||||||
Full Title: A Randomized, Double-Blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unresectable Melanoma | ||||||||||||||||||
Medical condition: Previously Untreated Metastatic or Unresectable Melanoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Ongoing) DE (Ongoing) AT (Ongoing) GB (GB - no longer in EU/EEA) SE (Ongoing) DK (Ongoing) FR (Ongoing) ES (Ongoing) GR (Ongoing) FI (Ongoing) PL (Ongoing) Outside EU/EEA IT (Ongoing) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.